Who Paid My Doc Search
Menu
Product Program year 2025 Source: CMS Open Payments

Avmapki Fakzynja Co-Pack

Drug KRAS Mutated Recurrent Low-grade Serous Ovarian Cancer (LGSOC)

NDC 71779-623-01

Open in the dashboard

General payments

$31,560

233 payments

Research payments

$0

0 payments

Through program year 2025, $31,560 in general payments and $0 in research payments were reported against Avmapki Fakzynja Co-Pack (KRAS Mutated Recurrent Low-grade Serous Ovarian Cancer (LGSOC)).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2025 General $31,560 233

Breakdown

Who paid General payments · program year 2025
  1. Verastem, Inc. $31,560 233 payments
Top recipients General payments · program year 2025
  1. Ie-Ming Shih Anatomic Pathology & Clinical Pathology · Baltimore, MD $3,575 11% · 2 payments
  2. Pei Hui Anatomic Pathology · New Haven, CT $3,575 11% · 2 payments
  3. Anna Yemelyanova Anatomic Pathology & Clinical Pathology · New York, NY $3,575 11% · 2 payments
  4. Ricardo Lastra Anatomic Pathology & Clinical Pathology · Chicago, IL $3,575 11% · 2 payments
  5. Kyle Devins Anatomic Pathology & Clinical Pathology · Boston, MA $3,300 10% · 2 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Anatomic Pathology & Clinical Pathology Pathology $17,064 56% · 5 practitioners
  2. Anatomic Pathology Pathology $6,175 20% · 2 practitioners
  3. Nurse Practitioner, Family Nurse Practitioner $1,655 5% · 36 practitioners
  4. Gynecologic Oncology Obstetrics & Gynecology $1,611 5% · 45 practitioners
  5. Nurse Practitioner $839 3% · 24 practitioners

The top 5 of 28 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Maryland $6,175 20% · 2 recipients
  2. California $4,033 13% · 15 recipients
  3. New York $3,797 12% · 11 recipients
  4. Connecticut $3,694 12% · 6 recipients
  5. Illinois $3,627 11% · 4 recipients

The top 5 of 24 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

Records

233 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record